Benzinga | Aug 3, 2021 04:50PM EDT

Global Blood Therapeutics Q2 EPS $(1.12) Beats $(1.19) Estimate, Sales $47.55M Beat $43.84M Estimate

Global Blood Therapeutics (NASDAQ:GBT) reported quarterly losses of $(1.12) per share which beat the analyst consensus estimate of $(1.19) by 5.88 percent. This is a 30.23 percent decrease over losses of $(0.86) per share from the same period last year. The company reported quarterly sales of $47.55 million which beat the analyst consensus estimate of $43.84 million by 8.47 percent. This is a 50.96 percent increase over sales of $31.50 million the same period last year.